Welcome to Medicor Cancer and Wellness Centres
Cancer and Chronic Disease Prevention & Therapy, Medical Ozone Therapy, Medically-Supported Vaping ProgramInnovative evidence-based non-toxic cancer treatment
- integrative treatment combining traditional and natural therapies
- leading experience worldwide with metabolic therapy using oral and intravenous dichloroacetate (DCA)
- metabolic therapy/immunotherapy: intravenous dimethylsulfoxide/sodium bicarbonate (DMSO/SB), developed by Ba Hoang, MD, PhD
- differentiating agent and glutamine inhibitor: sodium phenylbutyrate (oral and intravenous), developed by Stanislaw Burzynski, MD, PhD (“anti-neoplaston”)
- immunotherapy: oral low dose naltrexone (LDN) , developed by Bernard Bihari, MD
- zinc/manganese mineral infusion, developed by Ba Hoang, MD, PhD
- topical nanoparticle mineral-based lotion for skin cancers or skin metastases
- full complement of well-researched intravenous supportive infusions and natural therapies (high dose vitamin C, European mistletoe, amino acids, high dose B vitamins)
- advanced oral nanoparticle / liposomal formulations of melatonin, vitamin D and vitamin C
Powerful cancer prevention strategies
- the first medically-supported electronic cigarette program in Canada! (featuring products by SmokingVapor, Phoenix, AZ)
- nutritional optimization
- scientifically researched natural medicines
- high dose vitamin D
- treatment of conditions predisposing to cancer, such as autoimmune disease (rheumatoid arthritis, multiple sclerosis, Crohn’s disease, colitis, lupus etc.), genetic tendency (using epigenetic principles), correction of carcinogen exposure
Medical ozone therapy
- natural ozone therapy for a remarkably wide range of conditions
- blood ozonation (single and multi-pass), ozonated saline infusion, ozone insufflation, ozone joint injection combined with local anesthetic and natural medicines (Prolozone®), ozone perineural injection, spine injection (coming soon!)
- cancer therapy and therapy enhancement
- cancer prevention
- chemo, radiation and surgery preconditioning, enhance post-treatment healing
- anti-infective (therapy enhancement for viral hepatitis, HIV, EBV, Lyme, infected join replacements etc.)
- wound healing stimulation by natural stem cell release (e.g. chronic non-healing ulcers)
- nerve healing and regeneration (e.g. diabetic neuropathy, post-operative nerve injury)
- osteoarthritis pain reduction and cartilage regeneration
- anti-aging
- enhance circulation and tissue oxygenation (salvage limbs from amputation)
- chronic pain from torn rotator cuff, torn Achilles tendon, muscle injury, tennis elbow, golfer’s elbow, scars, plantar fasciitis, carpal tunnel syndrome, Morton’s neuroma
- American Academy of Ozone Therapy member and certified Prolozone® doctor (Medical Director Dr. Khan)
Platelet-Rich Plasma (PRP) therapy
- use of your blood platelets to help stimulate healing and repair in the body
- activated platelets release numerous growth factors, including transforming growth factor (TGF), platelet-derived growth factor (PDGF),vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), insulin-like growth factor (IGF), and interleukin-1 (IL-1)
- growth factors act on stem cells stimulating new blood vessel growth and regeneration
- very powerful when combined with ozone, for healing and regeneration (healing of osteoarthritis for example)
Dr. Khan Appears on DDP VRadio
Jul 2018 – Medicor’s Medical Director Dr. Akbar Khan appeared live on web cast DDP VRadio discussing innovative and powerful cancer therapies (such as SFE chemo and DCA) that the medical system refuses to accept.
Dr. Matsumura with William Hurt on CBS News
Dr. Matsumura holding a press conference on May 15, 2018 at the Berkeley Institute about SEF chemo. Medicor patients William Hurt and Mae LeBlanc discuss their treatment with SEF chemo, and the remarkable results.
In Sep 2017, the College of Physicians and surgeons of Ontario stopped Medicor’s Medical Director from administering the remarkable cancer therapy SEF chemo, despite the high success rate and demonstrated higher safety than conventional chemo. One of Canada’s leading criminal lawyers, Mr. Michael Code, formerly assistant Deputy Attorney General of Ontario, spent a year studying similar cases of the College’s actions against doctors practicing innovative therapies in Ontario. He said in a press conference:
“I reviewed … these doctors and the replies to them from the college which revealed to me a consistent pattern of unfairness in the way they were dealt with and a consistent pattern of improper use of powers and – arguably in some cases – even an abusive way of using powers. And, finally, what came through loud and clear, was a very strong bias against doctors working in innovative areas of medicine … and trying to find new solutions to new problems…”
“I would certainly invite the responsible government officials to look closely at whether the college is exercising its powers appropriately; whether this is the kind of Ontario, and the kind of medical climate, and medical community that we would all like to live in, whether it is appropriate that doctors are treated in this fashion.”
Dr. Khan Live on CityNews
Medicor’s Medical Director and Founder Dr. Akbar Khan appeared live on CityNews to discuss former Mayor Rob Ford’s cancer diagnosis (2014).
SIGN THIS PETITION TODAY TO HELP PATIENTS WITH CANCER!
- in Sep 2017 the College of Physicians and Surgeons stopped Medicor’s Medical Director from administering SEF chemo
- after a 3 year long investigation involving 4 separate consultants, the College appeared to ignore all documented evidence that showed SEF chemo was safer and more effective than many standard approved chemos
- suddenly the College felt there was a “grave concern” for patients POTENTIALLY being harmed by this therapy
- we expected they would be aware of the ACTUAL harm that comes from STANDARD APPROVED chemotherapy, and would have supported us instead (if they truly wish to “protect the public”)
- so far 2 patients who were receiving and responding to SEF chemo (who were not able to travel to California to continue) have sadly lost their lives
- please join us in telling the College this is unacceptable!
- sign the petition today, and contact your Provincial MPP to tell them it is unacceptable for promising safe and effective cancer therapies to be taken away from Canadians!
- if you wish to contact the College directly, you may call 1-800-268-7096 or email the lead investigator Lisa Mueller lmueller@cpso.on.ca and the Registrar registrar@cpso.on.ca
Sep 16, 2017 - Dr. Khan discusses "safe" chemo with Ted Woloshyn on Newstalk 1010
NOV 2017 METABOLIC CANCER CONFERENCE IN BALTIMORE WAS A BIG SUCCESS!
- a new concept in cancer therapy – the metabolic approach (diet, DCA, 3BP, glutamine blocking etc)
- over 40 speakers presented various topics
- many renowned doctors from USA, France, Taiwan, Canada, Greece, England and Turkey (Harvard, Johns Hopkins, U of Maryland, Columbia U, Stanford, Boston College, UCSF etc.)
- celebrity chefs and nutritionists
- Dr. Khan presented a lecture about DCA as a non-toxic metabolic cancer therapy, and moderated a panel discussion about chemotherapy
- videos of the entire conference will be available soon!
Shocking New Article by Tom Blackwell About Cancer Drugs
“…While an early stage study found the medicine shrunk tumours in about half of patients, there is no evidence…it helps them live longer or improves their quality of life. Still, manufacturer…charged a small fortune for the drug: about $122,000 a year.”
READ NOW!
New DCA Publication!
New peer-reviewed publication from Dr. Khan and Dr. Andrews in the World Journal of Clinical Oncology!
LONG TERM STABILIZATION OF METASTATIC MELANOMA WITH DCA (PDF) (HTML)
DCA therapy can result in a classic response which is measured by reduction or disappearance of tumours on imaging. However, DCA can also halt cancer cell growth without causing apoptosis (cytostatic effect). This can result in long-term stabilization of metastatic cancer. We present a case of oral DCA therapy resulting in reduction and stabilization of metastatic melanoma in a 32-year-old male for over 4 years, with only minor side effects.
Publications
Medicor’s medical director has published groundbreaking articles in various peer-reviewed medical journals around the world since 2011. He was the first to publish human data about dichloroacetate (DCA) in cancer symptom control, intravenous DCA as an effective cancer therapy, and the curative potential of DCA when combined with radiation. He has also published the world’s first case report on chronic use of DCA as a cancer stabilizing therapy, and a remarkable case report of cancer remission with low dose naltrexone (LDN) combined with high dose vitamin D. Read about Dr. Khan’s publications on the About our Medical Director page.
LDN RESEARCH TRUST MEMBER
Medicor supports, and is an active member of the LDN Research Trust, a registered charity (based in U.K.) dedicated to educating physicians and the public, and helping to fund novel research into low dose naltrexone. Dr. Akbar Khan is also a volunteer Medical Advisor for the LDN Research Trust.
CANADIAN VAPING ASSOCIATION MEMBER
Medicor supports the Canadian Vaping Association, an organization dedicated to promoting vaping as a safer alternative to cigarette smoking, and to informing and educating the public about the benefits of vaping.
CANADIAN SOCIETY FOR ORTHOMOLECULAR MEDICINE
Medicor’s medical director is a member of the Canadian Society for Orthomolecular Medicine. The CSOM is the foremost not-for-profit organization dedicated to the advancement of orthomolecular medicine within Canada. The Society serves to unite and support health care professionals with an interest in the science of nutritional biochemistry, and it’s application in the prevention and treatment of disease.
Smoking Vapor LLC Partner
Medicor is a proud partner of Smoking Vapor LLC of Phoenix, AZ, a manufacturer of premium electronic cigarettes. SV is focused on producing safe, high quality electronic cigarettes, designed to help smoker obtain satisfaction to make the switch with ease, and make a positive change in their lives.
Medicor doctors have been featured regularly in the media since 2006
